Dr. Timothy Grant McNaughton, MD

Dr. McNaughton practices at Windsor Court Assisted Living in Rancho Mirage, California.

Dr. McNaughton's NPI, 1124062039, was assigned on June 15, 2006. Dr. McNaughton graduated from David Geffen School of Medicine at UCLA in 2000. Dr. McNaughton holds California license A78159.

Dr. McNaughton's primary practice is Windsor Court Assisted Living, at 47 Provence Way, Rancho Mirage, CA 92270 in Riverside County. The practice phone is (760) 327-8351.

Dr. McNaughton's primary practice is Windsor Court Assisted Living in Rancho Mirage, California. Dr. McNaughton is also affiliated with Redlands Community Hospital. The medical group on file is Jovive Wound Care. Dmand AI also links Dr. McNaughton to 1 more hospital, 3 medical groups, 2 hospices, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McNaughton practices, 6 sites in all. Vendor and product names are available with a free account.

General practice is Dr. McNaughton's primary specialty in the NPI Registry, under taxonomy code 208D00000X. Dr. McNaughton is board certified in emergency medicine by the American Board of Emergency Medicine. Dr. McNaughton is licensed in California.

Dmand AI lists arthritis, cardiomyopathy, chronic diabetes, chronic skin ulcer, contact dermatitis, corns and calluses, peripheral vascular disease and varicose veins among the conditions Dr. McNaughton treats.

CMS data shows 157 Medicare services from Dr. McNaughton across 6 procedure codes in 2024, for 95 Medicare patients. Medicare paid $15,891 for them.

CMS counts 95 Medicare patients who saw Dr. McNaughton in 2024. The largest group is 65 to 74, with 28 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 48% are also on Medicaid. Their average risk score is 2.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McNaughton's median patient age at 73, with 55% women.

In 2024, Dr. McNaughton wrote 1,320 Medicare Part D claims for 205 patients. 90% of them were for generic drugs. CMS names the drug for 949 of them, across 33 drugs with 11 or more claims each, at $21,727 in total drug cost. In 2023, CMS named 884 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. McNaughton for performance year 2024, reported as part of a group. Dr. McNaughton accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 63 procedures of removal of tissue by Dr. McNaughton, more than 81% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. McNaughton. Dr. McNaughton's most frequent co-author is Robert Steele, MD.

CMS Open Payments shows 10 general payments to Dr. McNaughton from 6 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $114.

Dr. McNaughton graduated from David Geffen School of Medicine at UCLA in 2000.

Dr. McNaughton is in network with 7 carriers, including United Healthcare, Aspirus Health Plan and Blue Cross and Blue Shield of Kansas City. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.